Opinion
No. 1203 C.D. 2017
03-06-2018
BEFORE: HONORABLE P. KEVIN BROBSON, Judge HONORABLE ANNE E. COVEY, Judge HONORABLE ELLEN CEISLER, Judge
OPINION NOT REPORTED
MEMORANDUM OPINION BY JUDGE CEISLER
Jessica Givens (Licensee) appeals from the August 3, 2017 Order of the Court of Common Pleas of Dauphin County (Trial Court) dismissing Licensee's appeal from a one-year suspension of her operating privilege imposed by the Commonwealth of Pennsylvania, Department of Transportation, Bureau of Driver Licensing (DOT), under Section 1547(b)(1)(i) of the Vehicle Code, 75 Pa. C.S. § 1547(b)(1)(i). On appeal, Licensee argues that because the police officer who arrested Licensee did not warn her that she would be subject to enhanced criminal penalties if she refused a chemical test of her blood, as required by former Section 1547(b)(2)(ii) of the Vehicle Code, 75 Pa. C.S. § 1547(b)(2)(ii), DOT should not have suspended her operating privilege. We affirm.
Section 1547 of the Vehicle Code is commonly known as the Implied Consent Law. Section 1547(b)(1)(i) of the Implied Consent Law states:
If any person placed under arrest for a violation of section 3802 [of the Vehicle Code (relating to driving under the influence of alcohol or a controlled substance)] is requested to submit to chemical testing and refuses to do so, the testing shall not be conducted but upon notice by the police officer, [DOT] shall suspend the operating privilege of the person . . . for a period of 12 months.75 Pa. C.S. § 1547(b)(1)(i).
At the time of Licensee's arrest, Section 1547(b)(2)(ii) of the Implied Consent Law required a police officer to inform a licensee that "if the [licensee] refuses to submit to chemical testing, upon conviction or plea for violating section 3802(a)(1) [of the Vehicle Code], [he or she] will be subject to the penalties provided in section 3804(c) (relating to penalties)." Former 75 Pa. C.S. § 1547(b)(2)(ii) (emphasis added).
Section 1547(b)(2)(ii) now requires an officer to inform a licensee that "if the [licensee] refuses to submit to chemical breath testing, upon conviction or plea for violating section 3802(a)(1), [he or she] will be subject to the penalties provided in section 3804(c) (relating to penalties)." 75 Pa. C.S. § 1547(b)(2)(ii) (eff. July 20, 2017) (emphasis added).
On January 11, 2017, DOT notified Licensee that her operating privilege was suspended for one year due to her failure to submit to a blood test on December 24, 2016. Licensee appealed to the Trial Court.
The Trial Court held a hearing on March 28, 2017. At the hearing, the parties stipulated to the following facts. On December 24, 2016, Trooper Ricardo Carrera had reasonable grounds to suspect that Licensee had operated or had actual physical control of a vehicle in violation of Section 3802 of the Vehicle Code. N.T., 3/28/17, at 3-4. Trooper Carrera asked Licensee to provide a sample of her blood, but she refused. Id. at 5-6. Trooper Carrera then read to Licensee the warnings contained in DOT's Implied Consent Form DL-26B (Form DL-26B), which stated:
75 Pa. C.S. § 3802 (providing that "an individual may not drive, operate or be in actual physical control of the movement of a vehicle" while under influence of alcohol or controlled substance).
1. You are under arrest for driving under the influence of alcohol or a controlled substance in violation of Section 3802 of the Vehicle Code.Id. at 4-6; Ex. C-1, Item No. 2.
2. I am requesting that you submit to a chemical test of blood.
3. If you refuse to submit to the blood test, your operating privilege will be suspended for at least 12 months. If you previously refused a chemical test or were previously convicted of driving under the influence, you will be suspended for up to 18 months.
4. You have no right to speak with an attorney or anyone else before deciding whether to submit to testing. If you request to speak with an attorney or anyone else after being provided these warnings or you remain silent when asked to submit to a blood test, you will have refused the test.
Although Licensee did not sign Form DL-26B, she does not dispute that Trooper Carrera read the form to her verbatim. N.T., 3/28/17, at 3-4.
DOT created Form DL-26B in response to the United States Supreme Court's decision in Birchfield v. North Dakota, 136 S. Ct. 2160 (2016), which held that state laws imposing criminal penalties on motorists for refusing to submit to a blood test are unconstitutional. Form DL-26B eliminated the prior form's warning pertaining to enhanced criminal penalties for refusal to submit to a blood test. See Trial Ct. Op., 8/3/17, at 3-4.
In Birchfield, the Supreme Court concluded that "motorists cannot be deemed to have consented to submit to a blood test on pain of committing a criminal offense." 136 S. Ct. at 2186. The Supreme Court clarified, however, that its "prior opinions have referred approvingly to the general concept of implied-consent laws that impose civil penalties and evidentiary consequences on motorists who refuse to comply." Id. at 2185 (emphasis added); accord Boseman v. Dep't of Transp., Bureau of Driver Licensing, 157 A.3d 10, 21-22 (Pa. Cmwlth.), app. denied, 170 A.3d 996 (Pa. 2017) (holding that Birchfield does not apply to civil license suspensions).
On August 3, 2017, the Trial Court dismissed Licensee's appeal and reinstated the suspension of her operating privilege. Licensee timely appealed to this Court.
Our scope of review is limited to determining whether the Trial Court committed an error of law or abused its discretion and whether the Trial Court's factual findings are supported by substantial evidence. Reinhart v. Dep't of Transp., Bureau of Driver Licensing, 954 A.2d 761, 765 n.3 (Pa. Cmwlth. 2008). --------
On appeal, Licensee asserts that Trooper Carrera's failure to warn her of the possibility of enhanced criminal penalties for refusing a blood test violated former Section 1547(b)(2)(ii) of the Implied Consent Law and, therefore, DOT failed to satisfy its burden of proof. Licensee contends that until the General Assembly amended Section 1547(b)(2)(ii) in July 2017, Trooper Carrera was required to give Licensee the enhanced-penalty warning, even after Birchfield.
To suspend a licensee's operating privilege for refusing to submit to chemical testing, DOT must prove that:
(1) Licensee was arrested for violating Section 3802 of the Vehicle Code by a police officer who had "reasonable grounds to believe" that Licensee was operating or was in actual physical control of the movement of a vehicle while in violation of Section 3802 (i.e., while driving under the influence); (2) Licensee was asked to submit to a chemical test; (3) Licensee refused to do so; and (4) Licensee was specifically warned that a refusal would result in the suspension of his operating privileges and would result in enhanced penalties if he was later convicted of violating Section 3802(a)(1).Martinovic v. Dep't of Transp., Bureau of Driver Licensing, 881 A.2d 30, 34 (Pa. Cmwlth. 2005). Once DOT satisfies its burden of proof, the burden then shifts to the licensee to prove that he or she was incapable of making a knowing and conscious refusal. Hinkel v. Dep't of Transp., Bureau of Driver Licensing, 715 A.2d 556, 558 (Pa. Cmwlth. 1998).
Here, the parties stipulated that: Trooper Carrera had reasonable grounds to arrest Licensee for driving under the influence; Trooper Carrera asked Licensee to submit to a blood test; Licensee refused; and Trooper Carrera read to Licensee the implied consent warnings in Form DL-26B verbatim. N.T., 3/28/17, at 3-6. Moreover, Licensee does not allege that she was incapable of making a knowing and conscious refusal. Thus, the only issue before this Court is whether DOT's omission of the enhanced-penalty warning from Form DL-26B violated former Section 1547(b)(2)(ii) of the Implied Consent Law.
Our Court recently addressed this same issue in Garlick v. Dep't of Transp., Bureau of Driver Licensing, 176 A.3d 1030 (Pa. Cmwlth. 2018) (en banc). In Garlick, as in this case, the licensee argued that Form DL-26B failed to conform with the requirements of Section 1547(b)(2)(ii) because it did not include a warning that his refusal to submit to a blood test would subject him to enhanced criminal penalties. 176 A.3d at 1035. We noted that "the language contained in [former] Section 1547(b)(2)(ii) was mandatory at the time [the officer] requested that Licensee submit to a blood test." Id. at 1036. After Birchfield, however, enhanced criminal penalties for refusing a blood test are no longer constitutionally permissible. Consequently, at the time of his arrest, "Licensee could not, as a matter of constitutional law, be subject to such penalties. Stated simply, enhanced criminal penalties were not a consequence of Licensee's refusing the requested blood test." Id.
In rejecting the licensee's claim that the implied consent warnings in Form DL-26B were legally insufficient, we explained:
Licensee's argument is, in effect, that because the General Assembly did not immediately amend Section 1547(b)(2)(ii), DOT and the police had to continue to apply Section 1547(b)(2)(ii). However, the effect of Birchfield and the Superior Court cases that followed was to render the
criminal penalties warned of in Section 1547(b)(2)(ii) as applied to blood testing unenforceable and to effectively sever that section from the rest of the Vehicle Code. See Section 1925 of the Statutory Construction Act of 1972, 1 Pa. C.S. § 1925 ("[t]he provisions of every statute shall be severable" with certain exceptions not applicable here); Commonwealth v. Batts, 163 A.3d 410, 441 (Pa. 2017) (emphasis added) (stating that "[i]f a provision of a statute is invalidated for any reason . . . a court must sever it from the remaining, valid portion of the statute").Id. Therefore, we held that the officer's failure to warn the licensee that his refusal to submit to a blood test would subject him to enhanced criminal penalties, as required by Section 1547(b)(2)(ii) at the time of the arrest, did not mandate reversal of his suspension. Id. at 1037-38; see also Negovan v. Dep't of Transp., Bureau of Driver Licensing, 172 A.3d 733, 738 (Pa. Cmwlth. 2017) (upholding license suspension where police officer intentionally omitted enhanced-penalty warning when he read implied consent warnings to licensee who was arrested six days after Birchfield decision).
For the reasons set forth in Garlick, we conclude that DOT satisfied its burden of proving that Licensee was accurately warned of the only constitutionally permissible consequence of refusing a blood test at the time of her arrest: the suspension of her operating privilege.
Next, Licensee asserts that Section 1547(b)(2)(ii) of the Implied Consent Law is not severable from the remainder of the statute and, thus, DOT's omission of the enhanced-penalty warning from Form DL-26B contravened the statute's legislative purpose. As discussed above, however, this Court rejected a similar claim in Garlick and concluded that DOT's omission of the warning post-Birchfield was consistent with the statute's legislative intent. See 176 A.3d at 1036 (recognizing that legislative purpose of Section 1547(b)(2) is to inform licensee of consequences of refusal to submit to chemical test "so that he [or she] can make a knowing and conscious choice") (quotation omitted); see also Nardone v. Dep't of Transp., Bureau of Driver Licensing, 130 A.3d 738, 747 (Pa. 2015) (stating that Implied Consent Law also "serves the important purpose of notifying the driving community that motorists noncompliant with the proper administration of our chemical testing laws will be removed from our roadways swiftly through the civil penalty of license suspension"). Accordingly, we conclude that the Trial Court properly dismissed Licensee's appeal and reinstated the suspension of her operating privilege.
Order affirmed.
/s/_________
ELLEN CEISLER, Judge
ORDER
AND NOW, this 6th day of March, 2018, the Order of the Court of Common Pleas of Dauphin County, dated August 3, 2017, is hereby affirmed.
/s/_________
ELLEN CEISLER, Judge